Carmen Doran

Carmen Doran is the Chief Operating Officer at Helius Therapeutics. Carmen has over 20 years of experience in leadership roles in the pharmaceutical and biotech industry.

Carmen started their career at Novartis in 2013 as Head of Operations for Animal Health. Carmen then moved to Tracks Business Consulting Ltd where they were a Director and Consultant for 5 years. Carmen then took on an interim management role as General Manager/Site Head at Siegfried Holding AG from 2017-2018. Carmen returned to Tracks Business Consulting Ltd in 2019 before taking on their current role as Chief Operating Officer at Helius Therapeutics in 2020.

Throughout their career, Carmen has been focused on translating strategy into something real and making it happen. Carmen is also experienced in project and program management, as well as leadership coaching and operational excellence. Carmen works with a number of Global Partners to give the best experience and service to their customers.

Carmen Doran has a Masters (Distinction) in Biomedical Engineering and a Bachelor (1st Class) in Mechanical Engineering from the University of Canterbury. Carmen also has certification from The Open University in Certificate in Business Management, Changefirst in Change Excellence Practitioner, Novartis in Lean-Six-Sigma Black Belt, Kepner-Tregoe in Problem Solving & Decision Making, and Shingo Institute in Shingo Approach to Operational Excellence.

Carmen Doran reports to Paul Manning, Chief Executive Officer. Carmen Doran works with Dr Jim Polston - Chief Science Officer, Leila De Koster - Managing Director, Helius Animal Health, and Bruce Wallace - Chief Quality Officer.